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Abstract
Background: Old age is associated with an involuntary and progressive but physiological loss of muscle mass. The
aim of this study was to evaluate the effects of exclusive consumption for 6 months of a protein-enriched enteral
diet with a relatively high content of branched-chain amino acids on albuminemia, cortisolemia, plasma amino
acids, insulin resistance, and inflammation biomarkers in elderly patients.
Methods: Thirty-two patients from the Clinical Nutrition Outpatient Unit at our hospital exclusively consumed a
protein-enriched enteral diet for 6 months. Data were collected at baseline and at 3 and 6 months on
anthropometric and biochemical parameters and on plasma concentrations of amino acids, cortisol,
adrenocorticotropic hormone, urea, creatinine, insulin resistance, and inflammation biomarkers.
Results: The percentage of patients with albumin concentration below normal cut-off values decreased from 18%
to 0% by the end of the study. At 6 months, concentrations of total plasma (p = 0.008) and essential amino acids
(p = 0.011), especially branched-chain amino acids (p = 0.031), were higher versus baseline values, whereas
3-methylhistidine (p = 0.001), cortisol (p = 0.001) and adrenocorticotropic hormone (p = 0.004) levels were lower.
Conclusions: Regular intake of specific protein-enriched enteral formula increases plasma essential amino acids,
especially branched-chain amino acids, and decreases cortisol and 3-methylhistidine, while plasma urea and
creatinine remain unchanged.
Background
The proportion of the elderly is high and steadily rising
in Western populations [1]. Aging is associated with an
involuntary and progressive but physiological loss of
muscle mass, designated sarcopenia [2], which is cur-
rently considered an emerging problem of Public Health
[1]. Sarcopenia is accompanied by a reduction in
strength and quality that leads to muscle weakness, lim-
iting mobility and increasing vulnerability to injury [1,3].
Reduced muscle mass in older adults has also been
associated with susceptibility to disease and decreased
survival rates after critical illness [2].
Skeletal muscle is the body’s main reservoir of amino
acids, which contain 50-75% of human body proteins.
Skeletal muscle is a vital supplier of amino acids for use
as fuel by the brain and immune system and as a sub-
strate for tissue repair during malnutrition, injury, and
disease [4]. It is important to maintain the body protein
mass in order to live well and remain physically
independent.
It has been postulated that age-related muscle mass
reduction is due to a multi-factorial process that include
genetic and other factors such as cellular apoptosis,
changes in protein metabolism, hormonal alterations,
loss of neuromuscular function, inappropriate nutrition,
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any medium, provided the original work is properly cited.lack of regular physical activity, and diseases or their
sequelae [5]. The mechanisms underlying the loss of
skeletal muscle are not clear but can be linked to a pre-
ceding disruption in the regulation of muscle protein
turnover, specifically to an imbalance between protein
synthesis and breakdown [6]. It has been demonstrated
that the combination of prolonged inactivity and hyper-
cortisolemia increases muscle protein catabolism and
reduces muscle protein synthesis, even when substrates
are available [6]. Likewise, hypercortisolemia has been
observed in hypoalbuminemic individuals [7]. Albumin
is a good marker of protein malnutrition, and lower
concentrations are commonly observed in older subjects
and have been associated with poor health outcomes
and mortality [8].
Inflammatory cytokines such as interleukin (IL)-6 and
tumor necrosis factor alpha (TNF-a) contribute, together
with a reduced concentration of growth factors, to the
development of sarcopenia [1]. Insulin resistance (IR) is
also implicated in sarcopenia and is frequently observed
in elderly subjects, although it is mostly associated with
obesity and, recently, with sarcopenic obesity [9].
Co-ingestion of protein and leucine stimulates muscle
protein synthesis rates to the same extent in young and
elderly lean men [10], and the intake of nutrients and
proteins affects the albumin synthesis rate in humans
[11]. Ingestion of 15 g/d of whey protein, containing
6.5 g of essential amino acids (EAA), has been reported
to be strongly anabolic to skeletal muscle in healthy
older individuals [12]. Enteral nutrition (EN) formulas
are prescribed to elderly patients, when it is necessary,
as an exclusive diet or in combination with other foods
to achieve recommended dietary intakes. With this
background, the aim of this study was to evaluate the
effect of a six-month exclusive protein-enriched enteral
diet with a relatively high content of branched-chain
amino acids (BCAA) and other essential amino acids on
albuminemia, cortisolemia, plasma amino acids, IR, and
inflammation biomarkers in elderly patients subjected to
total enteral nutrition.
Methods
Study design
An experimental, prospective, intention-to-treat clinical
trial was performed in elderly patients recruited from
the Clinical Nutrition and Dietetics Outpatient Unit of
the Virgen de las Nieves University Hospital (Granada,
Spain). The patients were fed exclusively on an essential
amino acid-enriched enteral diet for 6 months. The pro-
tein blend comprised 50% caseinate, 25% whey protein,
and 25% pea protein (T-Diet Plus®, from Vegenat S.A.).
A previous study reported the protein efficiency ratio
(PER) of this blend to be 4.04 and the apparent digestive
coefficient to be 93.91% [13].
Patients received 1500 mL of this diet to meet their
daily energy and nutritional requirements. The actual
mean daily intake for the whole study period was
1266 ± 59 kcal. Table 1 shows the nutritional compo-
sition of the enriched protein enteral diet and Table 2
the amino acid composition. The diet was adminis-
tered as a bolus using a nasogastric tube or via a
stoma with a large-bore syringe. All patients received
1000-1200 mL of water daily to maintain optimal
hydration status.
Table 1 Nutritional composition of the specific protein-
enriched enteral formula*
Nutrients Per 100 mL
Energy kcal 100
Protein g 4.00
Casein g 2.00
Whey proteins g 1.00
Pea proteins g 1.00
Total Carbohydrates g 12.3
Total Fat g 3.90
Fiber g 1.70
Total Minerals g 0.57
*The product as it is marketed (T-Diet Plus®) contains a vitamin complex to
satisfy 100% of vitamin reference intake for elderly, assumed a daily intake of
1500 kcal (6276 kJ).
Table 2 Amino acid composition of the specific protein-
enriched enteral formula
Amino acid g/100 g protein
Alanine 4.02
Arginine 4.92
Aspartic Acid* 9.20
Cystine 1.05
Glutamic Acid* 22.68
Glycine 2.50
Histidine 2.52
Isoleucine 5.52
Leucine 9.67
Lysine 8.32
Methionine 2.47
Phenylalanine 4.87
Proline 9.09
Serine 5.27
Threonine 4.85
Tryptophan 1.32
Tyrosine 4.57
Valine 6.10
Branched-chain amino acids 21.29
Methionine + Cysteine 3.52
Phenylalanine + Tyrosine 9.44
* These values include asparragine and glutamine, which are converted to
aspartic and glutamic acid, respectively, during the protein hydrolysis carried
out in the analytical procedure
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Thirty-two patients (25 female, 7 male; mean age
70.1 ± 3.7 yrs) from the Clinical Nutrition and Diete-
tics Outpatient Unit of our hospital participated in the
study. Inclusion criteria were: age >65 years, prescrip-
tion of total enteral nutrition for ≥6m o n t h s ,a n d
voluntary consent to participate. Exclusion criteria
were: unstable clinical condition, fatal illness, inclusion
in other clinical trial, or refusal to participate. The
patient or next of kin was informed about the purpose
and procedures of the study before written consent
was obtained. The protocol was performed in accor-
dance with the Declaration of Helsinki and approved
by the Ethics Committee of our hospital. At the end of
the experimental period, only 17 of the 32 enrolled
patients remained in the study; 15 patients were lost to
the study due to: refusal to continue in the study (n =
6), death (n = 4), change in diet (n = 3) (two moved to
a nursing home in other province, and one was pre-
scribed a specific formula for diabetics due to his clini-
cal condition), and withdrawal of enteral nutrition (n =
2). Table 3 shows the baseline demographic and
anthropometric characteristics of the subjects and their
concomitant diseases and medication. A large propor-
tion of patients had cognitive deficits and a history of
cerebrovascular diseases and cardiovascular events.
The majority were receiving gastric protectors and a
large proportion psycho-drugs and anticoagulants.
Anthropometric measurements
No attempt was made to measure the weight or height
of the patients, who were mostly bed-bound. Measure-
ments were taken of the mid-arm circumference (MAC)
and tricipital skinfold (TS). The MAC (in cm) was mea-
sured midway between the tips of the acromion and ole-
cranon processes, using a flexible tape measure. The TS
(in mm) was taken on the dorsal arm midway between
the tips of the acromion and olecranon, using a caliper.
These measurements were compared with reference
tables for the elderly Spanish population classified by
age and sex [14].
Blood samples
Fasting blood samples were obtained from patients
between 8:00 and 10:00 am after 8-10 h overnight fast-
ing at baseline (before diet) and again after 3 and 6
months of the study diet. Serum and plasma (EDTA-
coated tubes from BD Vacutainer, Plymouth, UK) were
separated by centrifugation (15 min at 1750 g) and
immediately processed or divided into aliquots and fro-
zen at -80°C until their analysis.
Biochemical analysis
Plasma urea (Coefficient of Variation [CV 2.8%]), creati-
nine (CV 3.2%), albumin (CV 3%), and glucose (CV 1%)
were determined by standardized spectrophotometric
techniques using a Roche Hitachi Modular DDP clinical
analyzer system (Roche Diagnostics Spain, S.L., Barce-
lona). Cortisol (CV 1.7%) and adrenocorticotropin hor-
mone (ACTH) (CV 8.9%) were determined by
chemiluminescence usingaL I A I S O NI m m u n o a s s a y
Analyzer (Soaring S.T.A, Saluggia, Italy). Fasting insulin
(CV 2.6%) was analyzed by standardized electrochemilu-
minescence using an E-170 Elecsys Modular Analytics
system (Roche Diagnostics España, S.L., Barcelona). All
biochemical analyses were performed in the Virgen de
l a sN i e v e sU n i v e r s i t yH o s p i t a l .I Rw a sc a l c u l a t e db y
using the homeostatic assessment model (HOMA-IR),
defined by the equation HOMA-IR = fasting glucose
(mM) × fasting insulin (μU/mL)/22.5.
Inflammatory biomarkers
LINCOplex™kits (Linco Research, MO) were used on a
Luminex® 200™System (Luminex Corporation, TX) to
determine IL-6 (CV 7.8%), IL-8 (CV 7.9%), TNF-a (CV
7.8%) (Cat. #HADK2-61K-B), and adiponectin (CV
9.2%) (Cat. #HCVD1-67AK). C-reactive protein (C-RP)
(CV 4%) was determined with a particle-enhanced turbi-
dimetric immunoassay (PETIA) (Dade Behring Inc., IL).
Amino acid analysis
Plasma amino acids were determined by high-perfor-
mance liquid chromatography (HPLC) using a Beckman
Table 3 Baseline demographic and anthropometric
characteristics of the subjects, concomitant diseases and
medication
Demographic and anthropometric characteristics
Age (y) 70.1 ± 3.7*
Sex Female 25
Male 7
Tricipital Skinfold (mm) 17.6 ± 2.2
Mid Arm circumference (cm) 24.3 ± 1.0
Concomitant diseases (%)
Cognitive deficits and Alzheimer disease 52.9
Cerebrovascular diseases and cardiovascular events 41.2
Other causes (cancer, accidents) 17.6
Medication (%)
Gastric protectors 82.3
Psychodrugs 40.0
Anticoagulants 41.2
Antihypertension medication 25.0
Diuretics 30.0
Analgesics 20.0
Antiarrhythmics 15.0
Antidiabetics 5.0
*x ± SEM (for all such values).
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CA), which includes a solvent module 126AA, post col-
umn reactor 232, detector 168, autosampler 508, and a
3×250-mm spherogel AA lithium column (sulfonated
polystyrene-divinylbenzene copolymers), as previously
described by Le Boucher et al [15]. Lithium column elu-
ents Li-292, Li-365, and Li-375 and trione ninhydrin
reagent were from Pickering Laboratories (Mountain
View, CA), and norleucine was from Sigma (St. Louis,
MO).
Statistical analysis
Plasma cortisol, ACTH, urea, creatinine, IR, inflamma-
tion biomarkers, and amino acids are expressed as mean
values with standard error of the mean (SEM). The
anthropometric and albumin values are expressed as a
percentage of reference values for healthy individuals
[14]. Variables were checked for normality and homoge-
neous variance by using the Kolmogorov-Smirnov and
the Levene tests, respectively. As most of the data did
not follow a normal distribution, the non-parametric
Friedman test for three repeated measures was used to
assess differences as a function of treatment time. The
Wilcoxon test was used for post hoc comparisons to
analyze specific differences between times. Percentages
were compared using a chi-square test. Correlations
between different variables were assessed using the rank
Spearman test. A value of p < 0.05 was considered sig-
nificant. SPSS 15.01 for Windows (SPSS Inc., Chicago,
IL) was used for the data analyses.
Results
No significant differences in anthropometric measure-
ments were found between before and after consump-
tion of the enriched-protein enteral formula for 6
months. However, the percentage of subjects with albu-
m i nb e l o wt h en o r m a lp l a s m ac u t - o f fv a l u ef e l lf r o m
18% at baseline to 0% at 6 months (Table 4).
A ss h o w ni nF i g u r e1 A ,r e d u c t i o n sf r o mb a s e l i n e
values were observed in plasma ACTH (baseline,
15.37 ± 1.08 pmol/L; 3 months, 9.85 ± 0.83 pmol/L;
6 months, 9.56 ± 1.18 pmol/L; p = 0.004) and in plasma
cortisol (baseline, 423 ± 23 nmol/L; 3 months, 361 ± 35
nmol/L, 6 months, (257 ± 29 nmol/L; p = 0.001).
Total plasma amino acids progressively increased (Fig-
ure 1B) from 1963 ± 195 μmol/L at baseline to 2809 ±
175 μmol/L at six months (p = 0.008); essential amino
acids increased from 558 ± 64 μmol/L at baseline to 731
±3 4μmol/L (p = 0.023) at three months and remained
fairly constant later on. No changes were observed over
the study period in plasma urea or creatinine (Figure
1C), which remained at normal concentrations, while 3-
methylhistidine (Figure 1D) was unchanged at three
months but lower (p = 0.003) at six months. Total
plasma amino acids were negatively correlated with
plasma cortisol (r = -0.406, P < 0.007).
Specific plasma amino acid concentrations are
reported in Table 5. Between three and six months,
there were increased concentrations of leucine (p =
0.002), valine (p = 0.006), cysteine (p = 0.002), citrulline
(p = 0.006), glutamine (p = 0.008), asparagine (p =
0.001), phenylalanine (p = 0.015) and tyrosine (p =
0.017). In comparison to baseline values, threonine was
higher at three months (p = 0.017) and arginine at six
months (p = 0.004), while proline, histidine, and methio-
nine were higher at three months (p = 0.048, p =0 . 0 0 9 ,
and p = 0.012, respectively) but the same as baseline
concentrations at six months. Taurine increased pro-
gressively from baseline to six months (p = 0.001), while
alanine, glycine, isoleucine, serine, glutamic and aspartic
acids, lysine, ornithine, and hydroxyproline remained
largely unchanged.
Table 4 Albumin and anthropometric measurements
below the normal range in elderly patients receiving a
protein-enriched enteral diet for 6 months
Percentage of patients 0 mo 3 mo 6 mo P*
Albumin 18.8 6.3 0 0.060
Mid-arm circumference 31.3 23.5 29.4 0.874
Triceps skinfold 37.5 41.2 41.2 0.918
Undernutrition was defined by plasma albumin < 3 g/dL, mid-arm
circumference < 25th percentile, and triceps skinfold < 25th percentile by age
and sex in the elderly [14].
*Differences among sample times were tested using the chi-square test,
considering P < 0.05 to be significant.
Figure 1 Plasma concentrations of cortisol and acetylcholine
(A); total and essential amino acids (B); urea and creatinine (C);
and 3-methylhistidine (D) at baseline and at 3 and 6 month in
elderly patients exclusively receiving a protein-enriched enteral
diet. ACTH, adrenocorticotropin hormone; AA, amino acids; EAA,
essential amino acids. Differences between times were analyzed
using the Wilcoxon test, considering P < 0.05 to be significant. In
each group, superscript letters were significantly different.
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est are shown in Table 5. The ratio of nonessential to
essential amino acids (NEAA/EAA) was lower at three
months (p = 0.041) but similar to baseline at six
months. Between three and six months of the diet,
BCAA, Cys/Met ratio, and Whitehouse index increased
(p = 0.002, p = 0.002, p = 0.001, respectively) and the
Ala/Leu and Ala/BCAA ratios decreased (p =0 . 0 0 6 ,p =
0.012, respectively). The Ala/Thr was lower at six
months than at baseline (p = 0.001). No changes were
observed during the trial (at 3 or 6 months) in other
indexes (Table 5) or in insulin, HOMA-IR, adiponectin,
C-RP, IL-6, or IL-8 values (Table 6). TNF-a slightly
increased from three to six months (p = 0.041).
Discussion
The main findings of this study were that after six
months on an exclusive diet of specific protein-enriched
enteral formula with a relatively high content of BCAA
and other EAA, elderly patients showed a decrease in
plasma cortisol concentrations and an increase in total
plasma amino acid concentrations, especially of the
essential amino acids leucine, valine and the condition-
ally essential amino acids arginine and glutamine. The
plasma concentration of 3-methylhistidine, a biomarker
of protein breakdown, was also decreased in these
patients, but no changes were observed in creatinine, IR,
or inflammation biomarkers, except for a slight increase
in TNF-a a t6m o n t h s .T h e r ew a sat r e n dt oad e c r e a s e
in the percentage of patients with albumin levels below
normal range over the duration of the diet (P = 0.06,
Kendall’s tau b), thus, this percentage decreased to zero
after six months of the exclusive diet. These results sug-
gest that plasma albumin concentrations can be
increased by an adequate amount and quality of amino
acid intake.
The Aging and Body Composition [8] study reported
an association between low serum albumin concentra-
tion and greater loss of skeletal muscle mass. Compari-
son of the fractional synthesis rate (FSR) of albumin
Table 5 Plasma amino acid concentrations and indexes at
baseline and at 3 and 6 months in elderly patients
exclusively receiving a protein-enriched enteral diet
Amino Acids
(μmol/L)
0 mo 3 mo 6 mo P*
Aliphatic amino acids
Alanine 317 ± 33
† 315 ± 39 342 ± 32 .607
Glycine 143 ± 18 183 ± 20 208 ± 18 .168
Branched-chain amino
acids
Isoleucine 38 ± 4 41 ± 6 52 ± 3 .062
Leucine 68 ± 8
a ‡ 57 ± 6
a 96 ± 6
b .002
Valine 146 ± 22
ab 130 ± 12
a 178 ± 12
b .007
Hydroxyl amino acids
Threonine 87 ± 10
a 132 ± 20
b 150 ± 17
b .001
Serine 75 ± 7 77 ± 10 83 ± 7 .449
Sulfur amino acids
Taurine 7 ± 1
a 11 ± 3
b 102 ± 11
c <.001
Cysteine 20 ± 5
a 25 ± 8
a 68 ± 6
b <.001
Methionine 24 ± 7
a 59 ± 8
b 24 ± 1
a .002
Acidic amino acids
and amides
Glutamic Acid 47 ± 7 46 ± 8 46 ± 8 .766
Glutamine 454 ± 64
a 500 ± 102
a 968 ± 123
b .001
Aspartic Acid 7 ± 1 7 ± 1 6 ± 1 .189
Asparagine 43 ± 8
a 21 ± 6
a 71 ± 6
b .001
Aromatic amino acids
Phenylalanine 36 ± 5
a 37 ± 4
a 51 ± 3
b .015
Tyrosine 40 ± 4
a 38 ± 4
a 56 ± 5
b .017
Basic amino acids
Arginine 30 ± 4
a 44 ± 6
ab 54 ± 5
b .005
Citrulline 31 ± 7
a 25 ± 5
a 46 ± 4
b .006
Histidine 81 ± 14
a 130 ± 13
b 85 ± 5
a .022
Lysine 86 ± 12 114 ± 16 91 ± 5 .189
Ornithine 77 ± 14 99 ± 21 83 ± 7 .549
Imino acids
Hydroxyproline 12 ± 2 14 ± 2 8 ± 1 .257
Proline 190 ± 25
a 128 ± 13
b 194 ± 21
a .046
Amino Acid Indexes
NEAA/EAA 2.54 ± 0.14
a 2.34 ± 0.52
b 2.93 ± 0.20
a .008
BCAA (μmol/L) 256 ± 32
a 228 ± 16
a 326 ± 21
b .007
Alanine/
Threonine
3.85 ± 0.40
a 3.93 ± 0.41
ab 2.56 ± 0.31
b .017
Glycine/Valine 1.09 ± 0.15 2.12 ± 0.62 1.23 ± 0.12 .420
Alanine/Leucine 4.85 ± 0.40
a 5.78 ± 0.66
a 3.59 ± 0.27
b .004
Alanine/BCAA 1.36 ±
0.15
ab
1.35 ± 0.13
a 1.05 ± 0.07
b .017
Phenylalanine/
Tyrosine
0.92 ± 0.07 1.00 ± 0.06 0.96 ± 0.05 .449
Cysteine/
Methionine
1.46 ± 0.41
a 0.88 ± 0.40
a 2.80 ± 0.20
b .001
H Index 2.25 ± 0.22 2.52 ± 0.21 1.98 ± 0.13 .071
Whitehead Index 2.66 ± 0.25
a 2.50 ± 0.35
a 4.15 ± 0.43
b <.001
NEAA, nonessential amino acids; EAA, essential amino acids; BCAA, branched-
chain amino acids; H Index, relationship between the sum of serine, glycine,
and alanine concentrations and the BCAA concentration; Whitehead Index,
relationship between the sum of serine, glycine, glutamine, and taurine
concentrations and the sum of methionine and BCAA concentrations.
Tryptophan concentrations are not reported, because much of this amino acid
is bound to plasma proteins, which are eliminated during the deproteinization
step in the analytical procedure
* Differences among sample times were tested using Friedman test for three
repeated measures, considering P < 0.05 to be significant.
†x ± SEM (for all values)
‡ Differences between times were analyzed using the Wilcoxon test,
considering P < 0.05 to be significant. In each group, mean values within the
same row with unlike superscript letters were significantly different.
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rate was not affected by increasing age. However, the
FSR was reduced in individuals with an inadequate pro-
tein intake due to a reduction in the availability of
amino acid substrate [11]. Moreover, the ingestion of 15
g/d of a mixture of EAA for 3 months in older women
in a between meal fashion resulted in an increased basal
FSR and improvement of the lean body mass [16],
although these authors did not attempt to evaluate
whether the inclusion of both EAA and NEAA would
yielded the same results.
Efforts have been spent to mitigate sarcopenia in the
elderly using a variety of hormones without satisfactory
results [17]. However, the oral ingestion of EAA stimulates
muscle protein synthesis, without affecting muscle proteo-
lysis [10,11]. Sarcopenia has been associated with an ele-
vated cortisol concentration, and ACTH and cortisol
concentrations were reduced in our patients as a result of
the protein-enriched enteral diet. Cortisol is known to sti-
mulate the degradation and inhibit the synthesis of muscle
proteins [18]. One study of 26 middle-aged and 21 elderly
men found a negative relationship between cortisol and
muscle strength of the knee extensor [19], and another
study found a negative relationship between cortisol and
high physical performance in elderly subjects.
A major increase in leucine was achieved with the
present diet, suggesting a possible increase in protein
synthesis. In fact, leucine and insulin are the main regu-
lators of body protein synthesis, which is mediated by
the mTOR signaling pathway, involving type 1 phos-
phoinositide-3 kinase (PI3K) and protein kinase B (PKB/
Akt) [20]. Studies in old rats showed that protein synth-
esis was stimulated by supplementation with leucine
[21]. The same effect was observed by Rieu et al [22] in
the elderly and by Koopman et al. in both elderly and
young individuals [10]. Recent studies indicated that a
novel class type 3 PI3K, vacuolar protein sorting 34
(Vps34), which is stimulated by amino acids, primarily
by leucine, increases the production of PI3P. PI3P
recruits proteins containing FYVE or PX to enhance
phosphorylation and activation of mTOR, which finally
inhibits 4EBP-1 and activates S6K1 [20]. Compared with
the composition of the FAO/WHO reference protein
intake [23], the enteral diet used in the present study
supplied about twice the content of BCAA.
Some EAA and NEAA, including arginine, glutamine,
and proline, are important regulators of key metabolic
pathways that are necessary for maintenance, growth,
reproduction, and immunity in organisms, enhancing
protein secretion and improving health [24]. Glutamine
and proline metabolisms are interconnected via gluta-
mate and pyrroline-5-carboxilate and both amino acids
can serve as an important precursor for arginine [25].
Glutamine participates in protein synthesis, gluconeo-
genesis, inter-organ nitrogen transfer, nucleic acid bio-
synthesis, immune response, regulation of cellular redox
state, and ammonia detoxification [26] by shuttling
ammonia to the gut and kidney for excretion and as a
precursor to arginine and urea synthesis [25]. Arginine
is synthesized in the liver, but there is no net synthesis
via the hepatic urea cycle, because there is high arginase
activity to hydrolyze this amino acid. In adults, the
endogenous synthesis of arginine involves the intestinal-
renal axis [27]. Citrulline is synthesized from glutamine,
glutamic acid, and proline in the enterocyte, released
from the small intestine, and taken up primarily by kid-
neys for arginine production. Besides the kidney, citrul-
line is readily converted into arginine in nearly all types
of cells [27]. In our study, citrulline increased from 3 to
6 month of the enteral diet, indicating that it provided
sufficient substrates (i.e., glutamate and glutamine) for
its synthesis and explaining the increased plasma argi-
nine levels. The protein source used in the present
study is not only rich in glutamine but also in proline
(high proportion of casein) and arginine (pea protein
content).
Table 6 Insulin resistance and inflammatory biomarker concentrations at baseline and at 3 and 6 month in elderly
patients exclusively receiving a protein-enriched enteral diet
0m o 3m o 6m o P*
Insulin (mU/L) 3.12 ± 0.65
† 6.30 ± 1.32 4.62 ± 0.99 0.066
HOMA-IR 0.65 ± 0.13 1.41 ± 0.31 0.95 ± 0.20 0.087
Adiponectin (mg/mL) 18.7 ± 1.5 19.0 ± 1.6 20.3 ± 2.3 0.926
C-reactive protein (mg/L) 1.26 ± 0.44 1.58 ± 0.58 0.91 ± 0.28 0.886
Interleukin 6 (ng/L) 20.65 ± 4.10 29.36 ± 8.45 17.69 ± 6.29 0.424
Tumor Necrosis Factor alpha (ng/L) 4.28 ± 0.44
a ‡ 4.53 ± 0.44
a 5.42 ± 0.46
b 0.007
Interleukin 8 (ng/L) 6.35 ± 0.94 6.62 ± 1.88 5.38 ± 1.39 0.165
HOMA-IR, homeostasis model assessment for insulin resistance.
* Differences between times were analyzed using the Friedman test, considering P < 0.05 to be significant.
†x ± SEM (for all values).
Differences between times were analyzed using the Wilcoxon test, considering P < 0.05 to be significant. In each group, mean values within the same row with
unlike superscript letters were significantly different.
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of importance in health. The major end-products of
methionine and cysteine metabolism are glutathione
(GSH), homocysteine, and taurine, which have key roles in
the antioxidant defense system and in the intestinal
immune response. GSH is the major intracellular low-
molecular weight thiol and plays an important part in reg-
ulating the homeostasis of free radicals and cytoprotective
events [28]. The increase in cysteine levels between three
to six months on our diet is of interest, because cysteine is
the rate-limiting amino acid for GSH synthesis. There was
also an increase in taurine, which participates in maintain-
ing the antioxidant system and is the main component of
the free amino acid pool of lymphocytes, indicating its
potential importance in immune and proinflamatory
responses. Taurine is also involved in detoxification, mem-
brane stabilization, and retinal and cardiac function [26].
Hence, dietary supplementation using a protein source
with a high biological value and an adequate distribution
of both essential and semi-essential amino acids [13]
appears to be a good strategy to maintain plasma amino
acid levels and reduce glucocorticoids and muscle break-
down in the elderly. Thus, a decrease in plasma 3-methyl-
histidine intake was achieved with our enteral diet,
indicating a lesser protein breakdown, since this metabo-
lite cannot be reincorporated into proteins after its release
by protein degradation. Furthermore, there was no change
in creatinine, a biomarker of protein degradation, suggest-
ing maintenance of the muscular mass without reduction
of the arginine pool.
An inflammatory state is usually present in sarcopenia,
although it is more frequent in cancer patients. In the
elderly, however, the degree to which sarcopenia is asso-
ciated with a reduced insulin response and/or the pre-
sence of inflammatory factors is not clear. The increase
in IL-6 with age is well documented. Bautman et al.
observed an association between lower muscle perfor-
mance and higher IL-6 levels in hospitalized geriatric
patients [29], and Yende et al reported low quadriceps
strength in elderly individuals with high levels of IL-6
and TNF-a [30]. In the present study, the enteral diet
produced no changes in IR or increase in inflammation
biomarkers, (IL-6, IL-8 and C-RP), except in the case of
TNF-a which increased but remaining within normal
ranges, indicating that it did not induce an inflammatory
state or influence levels of pro-inflammatory cytokines,
while maintaining the homeostasis of nitrogen
metabolism.
Our study has some limitations, including the large
number of subjects who did not complete it, although
its duration was sufficient for some specific metabolic
changes to be observed. We were not able to measure
the FSR or other parameters directly related to protein
synthesis and muscle strength because of the clinical
condition of our patients, with the majority having
cognitive deficits.
Conclusion
Based on our findings, we can conclude that an enteral
diet with a specific blend of protein source with a high
proportion of BCCA, glutamate/glutamine, and arginine,
among other essential and conditionally essential amino
acids, increases plasma essential amino acids, especially
leucine, and decreases cortisol and 3-methylhistidine,
suggesting that protein synthesis is enhanced and pro-
tein degradation is reduced.
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